Background: Infantile hemangiomas are the most common vascular tumors of infancy,
affecting up to 12% of infants by the first year of life. Objective: To familiarize physicians with …

Propranolol and atenolol, current therapies for problematic infantile hemangioma (IH), are
composed of R (+) and S (–) enantiomers: the R (+) enantiomer is largely devoid of beta …

Propranolol is a well tolerated and effective treatment for infantile hemangiomas. The
efficacy of propranolol for infantile hemangiomas is clear, however questions pertaining to …

Effects of sclerosing agents on head and neck hemangiomas: A systematic review - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Perivascular and vascular neoplasms of the head and neck are a rare group of tumors
comprising a spectrum of clinical/biologic and histological features. They are frequently …

Background Vascular anomalies affect up to 5% of children with the majority affecting the
head and neck. They present at different ages as a wide variety of lesions. A careful …

Vascular anomalies have been classified as vascular tumors and vascular malformations
since 1982, when a pivotal article written by Mulliken and Glowacki 1 was published …

Vascular anomalies (VAs), broadly classified as nonmalignant tumors and malformations,
consist of a multitude of disorders that have a wide range of symptoms and complications as …

Introduction Propranolol has emerged as a first line agent in the management of
hemangiomas. With increased use of propranolol, studies have also focused on relapses …

Infantile hemangioma (IH) is a benign vascular tumor, presenting a unique sequence of
nonlinear growth and spontaneous involution. Some hemangiomas require opportune …